Back to top
more

Cross Country Healthcare (CCRN)

(Delayed Data from NSDQ)

$12.53 USD

12.53
403,582

-0.57 (-4.35%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $12.56 +0.03 (0.24%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 20% (196 out of 246)

Industry: Staffing Firms

Zacks News

Tracey Ryniec headshot

Value Investors: Stick with the Basics in 2022

A Zacks strong buy stock with a forward P/E of just 2.4? 5 great dirt-cheap stocks.

Zacks Equity Research

Zacks.com featured highlights include Atlas Air Worldwide, American Airlines, Cross Country Healthcare, Avnet, and Clearwater Paper

Atlas Air Worldwide, American Airlines, Cross Country Healthcare, Avnet, and Clearwater Paper are part of Screen of the Week article.

Maharathi Basu headshot

Swear on 5 Broker-Friendly Stocks to Weather Market Storms

For remarkable returns, investors should keep broker-friendly stocks like Atlas Air Worldwide Holdings (AAWW), American Airlines (AAL), Cross Country Healthcare (CCRN), Avnet (AVT), and Clearwater Paper (CLW) on their radar.

Ritujay Ghosh headshot

4 Staffing Stocks to Buy on Steady Job Additions in U.S.

The United States has been adding a record number of jobs, helping staffing stocks like Kforce Inc. (KFRC), Resources Connection (RGP), KornFerry International (KFY) and Cross Country Healthcare (CCRN).

Zacks Equity Research

Paychex (PAYX) Stock Up 23.6% in a Year: What's Behind It?

Consecutive better-than-expected top and bottom-line performance, shareholder-friendly moves and encouraging guidance have been benefiting the Paychex (PAYX) stock.

Zacks Equity Research

Cross Country Healthcare (CCRN) Q1 Earnings and Revenues Surpass Estimates

Cross Country (CCRN) delivered earnings and revenue surprises of 21.43% and 6.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Aptiv (APTV) to Report Q1 Earnings: What's in the Offing?

Aptiv's (APTV) first-quarter 2022 revenues are likely to have increased year over year.

Zacks Equity Research

What's in Store for Republic Services (RSG) in Q1 Earnings?

Republic Services' (RSG) first-quarter 2022 earnings and revenues are likely to have increased year over year.

Zacks Equity Research

Is a Beat in the Cards for FLEETCOR (FLT) in Q1 Earnings?

FLEETCOR's (FLT) first-quarter 2022 earnings and revenues are expected to have improved year over year.

Zacks Equity Research

Is a Beat Ahead for Opendoor Technologies' (OPEN) Q1 Earnings?

Opendoor Technologies' (OPEN) first-quarter 2022 revenues are expected to have benefited from an increase in home purchases.

Zacks Equity Research

Kforce (KFRC) Q1 Earnings and Revenues Beat Estimates

Kforce (KFRC) delivered earnings and revenue surprises of 22.37% and 2.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

What's in Store for Trane Technologies (TT) in Q1 Earnings?

Trane Technologies' (TT) first-quarter 2022 revenues are likely to have increased year over year.

Zacks Equity Research

Will Cross Country Healthcare (CCRN) Beat on Earnings in Q1?

Cross Country Healthcare's (CCRN) first-quarter 2022 earnings and revenues are expected to have increased year over year.

Zacks Equity Research

What's in the Cards for Marathon Digital (MARA) in Q1 Earnings?

Marathon Digital's first-quarter 2022 earnings and revenues are expected to have increased year over year.

Zacks Equity Research

Blucora (BCOR) to Report Q1 Earnings: What's in the Cards?

Blucora's (BCOR) first-quarter 2022 earnings and revenues are likely to have improved year over year.

Zacks Equity Research

Clean Harbors (CLH) to Report Q1 Earnings: What's Ahead?

Clean Harbors' (CLH) first-quarter 2022 earnings and revenues are likely to have improved year over year.

Zacks Equity Research

What Awaits International Money Express (IMXI) in Q1 Earnings?

International Money Express' (IMXI) first-quarter 2022 earnings and revenues are likely to have improved year over year.

Zacks Equity Research

Is a Beat in the Cards for Broadridge (BR) in Q3 Earnings?

Broadridge's (BR) third-quarter fiscal 2022 earnings and revenues are expected to have increased year over year.

Zacks Equity Research

What's in the Cards for S&P Global (SPGI) in Q1 Earnings?

S&P Global's (SPGI) first-quarter 2022 earnings are expected to have declined year over year while revenues are likely to have improved.

Zacks Equity Research

Verisk (VRSK) to Report Q1 Earnings: What's in the Offing?

Verisk's (VRSK) first-quarter 2022 earnings are likely to have benefited from organic growth within the business, lower interest expenses, lower effective tax rate, and a lower average share count.

Zacks Equity Research

Zacks.com featured highlights Revolve Group, Olympic Steel, Boise Cascade, Watsco and Cross Country Healthcare

Revolve Group, Olympic Steel, Boise Cascade, Watsco and Cross Country Healthcare have been highlighted in this Screen of The Week article.

Zacks Equity Research

Gartner (IT) to Report Q1 Earnings: What's in the Cards?

Gartner's (IT) first-quarter 2022 earnings are expected to have declined year over year while revenues are likely to have improved.

Sanghamitra Saha headshot

5 DuPont-Tested Winning Stocks to Buy Now

Use the DuPont technique to pick solid profit-generating stocks.

    Zacks Equity Research

    Cross Country Healthcare (CCRN) Earnings Expected to Grow: Should You Buy?

    Cross Country (CCRN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Zacks Equity Research

    Visa's (V) Q2 Earnings Beat Estimates on Solid Payments Volume

    Visa's (V) fiscal second-quarter results indicate better payments volume, processed transactions and cross-border volume, partly offset by high operating costs.